![Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy](https://www.cell.com/cms/asset/fb282b4e-87cf-4544-b03a-7510b259f329/fx1.jpg)
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy
![Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine](https://www.thelancet.com/cms/asset/2e79c946-a76f-459d-8e49-c3f1fef08276/gr1.jpg)
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine
![A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21037-2/MediaObjects/41467_2021_21037_Fig1_HTML.png)
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications
![Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_714096_16528853118824333.jpg)
Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients
![Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia - eBioMedicine Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia - eBioMedicine](https://www.thelancet.com/cms/asset/6656a1d3-128c-4be6-a82f-e75153651663/gr1.jpg)
Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia - eBioMedicine
![Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ](https://www.bmj.com/content/bmj/378/bmj-2022-071502/F1.medium.jpg)
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ
![Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates | Signal Transduction and Targeted Therapy Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-021-00861-4/MediaObjects/41392_2021_861_Fig4_HTML.png)
Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates | Signal Transduction and Targeted Therapy
![Moderna on X: "Additionally, a therapeutic vaccine (mRNA-1195) against long- term EBV sequelae, such as #MultipleSclerosis (MS) and post-transplant lymphoproliferative disease (PTLD) is in preclinical development. https://t.co/88ehVxosyT" / X Moderna on X: "Additionally, a therapeutic vaccine (mRNA-1195) against long- term EBV sequelae, such as #MultipleSclerosis (MS) and post-transplant lymphoproliferative disease (PTLD) is in preclinical development. https://t.co/88ehVxosyT" / X](https://pbs.twimg.com/media/FOoDi-JVQAIZcbW.jpg:large)
Moderna on X: "Additionally, a therapeutic vaccine (mRNA-1195) against long- term EBV sequelae, such as #MultipleSclerosis (MS) and post-transplant lymphoproliferative disease (PTLD) is in preclinical development. https://t.co/88ehVxosyT" / X
![Biomolecules | Free Full-Text | Cataloguing and Selection of mRNAs Localized to Dendrites in Neurons and Regulated by RNA-Binding Proteins in RNA Granules Biomolecules | Free Full-Text | Cataloguing and Selection of mRNAs Localized to Dendrites in Neurons and Regulated by RNA-Binding Proteins in RNA Granules](https://pub.mdpi-res.com/biomolecules/biomolecules-10-00167/article_deploy/html/images/biomolecules-10-00167-g001.png?1583559163)
Biomolecules | Free Full-Text | Cataloguing and Selection of mRNAs Localized to Dendrites in Neurons and Regulated by RNA-Binding Proteins in RNA Granules
![Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-25134-0/MediaObjects/41598_2022_25134_Fig1_HTML.png)
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports
![Long-term predictions of humoral immunity after two doses of BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | medRxiv Long-term predictions of humoral immunity after two doses of BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/10/18/2021.10.13.21264957/F2.large.jpg)